They should not get sick with that specific flu (but could with others).
If the patient has antibodies against the influenza virus, the antibodies will bind to the virus particles present in the serum. This binding will lead to the formation of virus-antibody complexes. These complexes will then activate the complement system, leading to the lysis of red blood cells through the classical pathway of complement activation.
these are the allo antibodies produced against the foreign cells in a transfused patient usually foun in patients with multiple transfusions
The red blood cells are destroyed by antibodies produced by the patient's own body (autoantibodies).
Vaccination is only a preventative measure, it will not cure influenza.
Theoretically it is possible to get antibodies from the serum of recovered patient of H1N1. But it will be available in very less quantity. Second question is to whom you will give these antibodies. Thirdly the protection will not be lasting. As this is passive immunity.
When a patient acts against a physicians orders, the physician is able to refuse the patient further care. The patient gives his or her opinion and if you don't follow directions they may wish to terminate your patient status.
Indirect immunofluorescence assay (IFA) is commonly used to detect anti-Rickettsia antibodies in a patient. This test involves exposing the patient's serum to Rickettsia antigens and then using fluorescently labeled antibodies to detect any bound antibodies. Positive results indicate a past or current infection with Rickettsia bacteria.
Yes, lupus antibodies can *come and go*. Usually antibodies remain present in the patient, but they may be more difficult to find in a blood test. It is possible to have lupus and have negative antibodies.
hyperimmune specific antibodies
One code is 90471. There is a 2nd code for the actual influenza vaccine, but we need to know the age of the patient.
Western blotting. When Western blotting is used for identification purposes, proteins from a known organism are used to determine whether a patient's serum contains antibodies.
Red blood cells